Life Scientist > Lab Technology

LabTech Systems undergoes name change, now LBT Innovations

23 November, 2009 by Tim Dean

Name changed to give company "more distinct corporate identity".


Aussie scientists pick up international accolades

17 November, 2009 by Tim Dean

Prince Henry's Institute researchers pick up prestigious medals from UK Society of Endocrinology.


Life Scientist of the Year announced

28 October, 2009 by Staff Writers

Professor Michael Cowley awarded 2009 Science Minister’s Prize for Life Scientist of the Year for work on obesity and diabetes.


Feature: Biotechs prepare for life after the GFC

28 October, 2009 by Tim Dean

The global financial crisis has battered the Australian biotechnology sector, but the signs suggest the storm is passing and the sun could be set to shine again.


Victoria simplifies clinical trial approval process

28 October, 2009 by Tim Dean

Ethical reviews for multi-site trials will only require a single approval.


Product Wars: Survival gadgets

18 September, 2009 by ARN Staff

If the Tom Hanks movie Cast Away is anything to go by, being marooned on a deserted island is not much fun.


Government calls on CSIRO to improve Centrelink

02 September, 2009 by Tim Dean

Five year research alliance between CSIRO and Centrelink to improve service delivery.


Good remains chair of NHMRC

02 September, 2009 by Tim Dean

New National Health and Medical Research Council appointed for 2009-2012 term.


Unravelling the haplotype

22 July, 2009 by Tim Dean

July/August 2009 issue of Australian Life Scientist is out now!


iSOFT has luck of the Irish

14 July, 2009 by Staff Writers

iSOFT wins $17.4m in contract extensions in Northern Ireland for Clinicom patient management system.


Special feature: Lord of the Z ring

03 July, 2009 by Fiona Wylie

Bacteriologist Elizabeth Harry revolutionised her field by working out a better way to watch bacteria do their thing. And what she found was more than she ever expected.


Patrys Announces $6.8 Million Rights Issue

29 June, 2009 by Staff Writers

Patrys Limited (ASX:PAB) announces a renounceable pro-rata rights issue to eligible shareholders.


Scientific fraud more common than thought

01 June, 2009 by Staff Writers

May be most prevalent in medicine and pharmacology


Australian biotech market today 27/5/09

27 May, 2009 by Staff Writers

ResMed, Ramsey


High times for high content screening

15 May, 2009 by Staff Writers

It was only 10 years ago that the first high content screening instrument rolled off the production line, and less than three since they started to appear in basic research laboratories.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd